Capricor Therapeutics
CAPR
CAPR
25 hedge funds and large institutions have $6.64M invested in Capricor Therapeutics in 2020 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 6 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
42% less call options, than puts
Call options by funds: $995K | Put options by funds: $1.71M
67% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 12
Holders
25
Holding in Top 10
–
Calls
$995K
Puts
$1.71M
Top Buyers
| 1 | +$1.61M | |
| 2 | +$868K | |
| 3 | +$441K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$355K |
| 5 |
Bank of New York Mellon
New York
|
+$317K |
Top Sellers
| 1 | -$914K | |
| 2 | -$264K | |
| 3 | -$200K | |
| 4 |
Goldman Sachs
New York
|
-$179K |
| 5 |
Two Sigma Advisers
New York
|
-$97K |